Experimental group:Tacrolimus

3 trials

Sponsors

Shenzhen Second People's Hospital, Shijiazhuang People's Hospital, People’s Hospital of Songzi

Conditions

Idiopathic membranous nephropathyMembranous nephropathymyasthenia gravis

Phase 4

The efficacy and safety of tacrolimus monotherapy in the treatment of idiopathic membranous nephropathy: an open, prospective, real-world study

Active, not recruitingChiCTR2000032422

Shenzhen Second People's HospitalIdiopathic membranous nephropathy

Start: 2020-09-01Updated: 2020-05-04

Study on the dominant population of tacrolimus in the treatment of myasthenia gravis

Active, not recruitingChiCTR2200057193

Shijiazhuang People's Hospitalmyasthenia gravis

Start: 2022-03-02Updated: 2023-10-03

Unknown Phase

Clinical assessment of tacrolimus in treating patients with membranous nephropathy: A protocol for systematic review and meta-analysis

Active, not recruitingChiCTR2200058661

People’s Hospital of SongziMembranous nephropathy

Start: 2022-04-01Updated: 2024-01-14